Results 241 to 250 of about 80,709 (284)
Some of the next articles are maybe not open access.

Erythropoietin in Obstetrics

Hematology/Oncology Clinics of North America, 1994
The physiology of maternal and fetal erythropoiesis in pregnancy shows that hematopoiesis, and the stimulation of hematopoiesis, take place separately in the two circulations. Erythropoietin appears the main regulator in both mother and fetus. The human placenta forms a manifest barrier to endogenous and recombinant erythropoietin, thus fulfilling the ...
R, Huch, A, Huch
openaire   +2 more sources

The Search for Erythropoietin

New England Journal of Medicine, 1971
Studies of the regulation of red-cell production have recently taken on some urgency because of the potential usefulness of erythropoietin in the treatment of patients with anemia due to chronic re...
openaire   +2 more sources

The erythropoietin receptor

The International Journal of Biochemistry & Cell Biology, 1999
The erythropoietin (epo) receptor is a member of the cytokine receptor family. It is expressed almost exclusively on erythroid precursor cells and controls the development of red blood cells. The epo receptor has no intrinsic kinase activity, but binds intracellular tyrosine kinases to elicit its signals.
P A, Tilbrook, S P, Klinken
openaire   +2 more sources

Erythropoietin and Analogs

2009
Erythropoietin (EPO), a glycoprotein hormone, stimulates the growth of red blood cells and as a consequence it increases tissue oxygenation. This performance enhancing effect is responsible for the ban of erythropioetin in sports since 1990. Especially its recombinant synthesis led to the abuse of this hormone, predominatly in endurance sports.
Christian, Reichel, Günter, Gmeiner
openaire   +2 more sources

The use of erythropoietin

Veterinary Clinics of North America: Small Animal Practice, 2003
EPO is a hematopoietic growth factor produced in the kidney that stimulates erythropoiesis. It effectively treats hypoproliferative anemia associated with CRF, improving quality of life in these patients. Other uses that are poorly characterized in veterinary medicine include treatment of cancer patients on chemotherapy, hematologic disorders, and ...
Cathy E, Langston   +2 more
openaire   +2 more sources

Endogenous Erythropoietin

2017
We sought to briefly describe current models of endogenous erythropoietin (EPO) pleiotropic properties to make four points clear. First, endogenous EPO regulates erythroid cell apoptosis so that red blood cell production is balanced against the number of cells destroyed in order to maintain optimal tissue oxygen levels (i.e., consistent with provision ...
Steven J, Korzeniewski, Athina, Pappas
openaire   +2 more sources

Withdrawal of erythropoietin

Nursing Standard, 1991
Withdrawal of erythropoietin from patients undergoing dialysis might precipitate a rebound of physical and psychological morbidity, researchers say.
openaire   +2 more sources

Recombinant Erythropoietin

Pediatrics In Review, 1991
Cloning and expression of the human gene encoding erythropoietin has resulted in the availability of recombinant erythropoietin for clinical and laboratory investigation. Results of such investigations are clarifying the mechanisms that regulate production of erythropoietin in health and disease.
openaire   +2 more sources

STAT5 as a Key Protein of Erythropoietin Signalization

International Journal of Molecular Sciences, 2021
Peter Solar   +2 more
exaly  

Erythropoietin

DMW - Deutsche Medizinische Wochenschrift, 2008
H, Pagel, W, Jelkmann
openaire   +2 more sources

Home - About - Disclaimer - Privacy